Lv71
5005 积分 2020-08-24 加入
HSP90 inhibitor-loaded hollow mesoporous nanoparticles for enhanced synergistic mild photothermal/chemotherapy in triple negative breast cancer
7天前
已完结
Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non–small-cell lung cancer
13天前
已完结
Sonodynamic therapy-derived multimodal synergistic cancer therapy
25天前
已完结
Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC)
27天前
已完结
Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway
27天前
已完结
TP53-centric ctDNA complements PET/CT for non-invasive assessment of pathological complete response and survival after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a prospective cohort study
27天前
已关闭
Interplay and cooperation between GLI2 and master transcription factors promote progression of esophageal squamous cell carcinoma
27天前
已完结
Dual‐Mode Radiosensitization of Esophageal Squamous Cell Carcinoma via SOCS6‐Loaded Virus‐Inspired Manganese‐Bismuth Bimetallic Oxide Nanoparticles
27天前
已完结
NOTCH1 Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 Trial
27天前
已完结
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
27天前
已完结
皖公网安备34019202002308
